Imatinib in melanoma: a selective treatment option based on KIT mutation status?
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 21, 2016
|
| In: |
Journal of clinical oncology
Year: 2007, Volume: 25, Issue: 7, Pages: e9 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2006.08.9664 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.2006.08.9664 Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/JCO.2006.08.9664 
|
| Author Notes: | Jürgen C. Becker and Eva B. Bröcker, Dirk Schadendorf and Selma Ugurel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1747497711 | ||
| 003 | DE-627 | ||
| 005 | 20241128143850.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210205r20162007xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.2006.08.9664 |2 doi | |
| 035 | |a (DE-627)1747497711 | ||
| 035 | |a (DE-599)KXP1747497711 | ||
| 035 | |a (OCoLC)1341391782 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Becker, Jürgen C. |d 1964- |e VerfasserIn |0 (DE-588)129853437 |0 (DE-627)481957863 |0 (DE-576)216700434 |4 aut | |
| 245 | 1 | 0 | |a Imatinib in melanoma |b a selective treatment option based on KIT mutation status? |c Jürgen C. Becker and Eva B. Bröcker, Dirk Schadendorf and Selma Ugurel |
| 264 | 1 | |c September 21, 2016 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Elektronische Reproduktion der Druckausgabe | ||
| 500 | |a Gesehen am 05.02.2021 | ||
| 534 | |c 2007 | ||
| 700 | 1 | |a Bröcker, Eva-Bettina |d 1946- |e VerfasserIn |0 (DE-588)1095924982 |0 (DE-627)856491934 |0 (DE-576)467873984 |4 aut | |
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 700 | 1 | |a Ugurel, Selma |d 1971- |e VerfasserIn |0 (DE-588)122030923 |0 (DE-627)081693532 |0 (DE-576)293057567 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 25(2007), 7, Seite e9 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnas |a Imatinib in melanoma a selective treatment option based on KIT mutation status? |
| 773 | 1 | 8 | |g volume:25 |g year:2007 |g number:7 |g pages:e9 |g extent:1 |a Imatinib in melanoma a selective treatment option based on KIT mutation status? |
| 856 | 4 | 0 | |u https://doi.org/10.1200/JCO.2006.08.9664 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://ascopubs.org/doi/10.1200/JCO.2006.08.9664 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210205 | ||
| 993 | |a Article | ||
| 994 | |a 2007 | ||
| 998 | |g 122030923 |a Ugurel, Selma |m 122030923:Ugurel, Selma |d 60000 |e 60000PU122030923 |k 0/60000/ |p 4 |y j | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1747497711 |e 3849199665 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"1 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Jürgen C. Becker and Eva B. Bröcker, Dirk Schadendorf and Selma Ugurel"]},"id":{"eki":["1747497711"],"doi":["10.1200/JCO.2006.08.9664"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"September 21, 2016"}],"recId":"1747497711","relHost":[{"recId":"313116962","pubHistory":["1.1983 -"],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"title":[{"title":"Journal of clinical oncology","title_sort":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal"}],"language":["eng"],"disp":"Imatinib in melanoma a selective treatment option based on KIT mutation status?Journal of clinical oncology","part":{"text":"25(2007), 7, Seite e9","issue":"7","volume":"25","extent":"1","pages":"e9","year":"2007"},"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"display":"American Society of Clinical Oncology","role":"isb"}],"id":{"issn":["1527-7755"],"zdb":["2005181-5"],"eki":["313116962"]},"origin":[{"publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","dateIssuedDisp":"1983-","dateIssuedKey":"1983"}]}],"note":["Elektronische Reproduktion der Druckausgabe","Gesehen am 05.02.2021"],"title":[{"title":"Imatinib in melanoma","title_sort":"Imatinib in melanoma","subtitle":"a selective treatment option based on KIT mutation status?"}],"language":["eng"],"person":[{"family":"Becker","display":"Becker, Jürgen C.","given":"Jürgen C.","role":"aut"},{"family":"Bröcker","display":"Bröcker, Eva-Bettina","given":"Eva-Bettina","role":"aut"},{"given":"Dirk","role":"aut","family":"Schadendorf","display":"Schadendorf, Dirk"},{"display":"Ugurel, Selma","family":"Ugurel","role":"aut","given":"Selma"}]} | ||
| SRT | |a BECKERJUERIMATINIBIN2120 | ||